Indaptus Therapeutics Stock Price Patterns
| INDP Stock | USD 2.21 0.02 0.91% |
Momentum 58
Buy Extended
Oversold | Overbought |
Using Indaptus Therapeutics hype-based prediction, you can estimate the value of Indaptus Therapeutics from the perspective of Indaptus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Indaptus Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Indaptus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Indaptus Therapeutics after-hype prediction price | USD 2.19 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Indaptus Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Indaptus Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Indaptus Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Indaptus Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Indaptus Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Indaptus Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Indaptus Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Indaptus Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Indaptus Therapeutics' historical news coverage. Indaptus Therapeutics' after-hype downside and upside margins for the prediction period are 0.11 and 10.79, respectively. We have considered Indaptus Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Indaptus Therapeutics is extremely dangerous at this time. Analysis and calculation of next after-hype price of Indaptus Therapeutics is based on 3 months time horizon.
Indaptus Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Indaptus Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Indaptus Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Indaptus Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 8.60 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.21 | 2.19 | 0.00 |
|
Indaptus Therapeutics Hype Timeline
Indaptus Therapeutics is currently traded for 2.21. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Indaptus is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is currently at -0.23%. %. The volatility of related hype on Indaptus Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 2.21. About 36.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.12. Some equities with similar Price to Book (P/B) outperform the market in the long run. Indaptus Therapeutics recorded a loss per share of 29.03. The entity last dividend was issued on the 30th of October 2020. The firm had 1:28 split on the 27th of June 2025. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Indaptus Therapeutics Basic Forecasting Models to cross-verify your projections. To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.Indaptus Therapeutics Related Hype Analysis
Having access to credible news sources related to Indaptus Therapeutics' direct competition is more important than ever and may enhance your ability to predict Indaptus Therapeutics' future price movements. Getting to know how Indaptus Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Indaptus Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SLXN | Biomotion Sciences Ordinary | 0.00 | 0 per month | 0.00 | (0.09) | 15.09 | (8.19) | 37.24 | |
| REVB | Revelation Biosciences | 0.00 | 0 per month | 0.00 | (0.26) | 5.56 | (9.09) | 35.57 | |
| PBM | Psyence Biomedical Ltd | 0.00 | 0 per month | 0.00 | (0.23) | 9.41 | (13.79) | 96.66 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 0.00 | 0.22 | 20.00 | (6.00) | 68.90 | |
| GTBP | GT Biopharma | 0.00 | 0 per month | 6.87 | 0.05 | 10.84 | (9.84) | 51.03 | |
| ATXI | Avenue Therapeutics | 0.00 | 0 per month | 0.00 | (0.18) | 12.66 | (20.69) | 50.24 | |
| PTIX | Protagenic Therapeutics | 0.00 | 0 per month | 0.00 | (0.17) | 14.81 | (15.25) | 58.73 | |
| SLRX | Salarius Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.19) | 17.35 | (18.03) | 51.00 | |
| LIPO | Lipella Pharmaceuticals Common | 0.00 | 0 per month | 0.00 | (0.12) | 17.07 | (16.00) | 44.95 | |
| AZTR | Azitra Inc | 0.00 | 0 per month | 0.00 | (0.14) | 6.90 | (10.53) | 34.09 |
Indaptus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Indaptus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Indaptus using various technical indicators. When you analyze Indaptus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Indaptus Therapeutics Predictive Indicators
The successful prediction of Indaptus Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Indaptus Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Indaptus Therapeutics based on analysis of Indaptus Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Indaptus Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Indaptus Therapeutics's related companies.
Pair Trading with Indaptus Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Indaptus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Indaptus Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Indaptus Stock
| 0.48 | T | ATT Inc Earnings Call This Week | PairCorr |
| 0.4 | PG | Procter Gamble | PairCorr |
| 0.32 | KO | Coca Cola Aggressive Push | PairCorr |
The ability to find closely correlated positions to Indaptus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Indaptus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Indaptus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Indaptus Therapeutics to buy it.
The correlation of Indaptus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Indaptus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Indaptus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Indaptus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.